Renal Unit, Department of Clinical and Experimental Medicine, University of Messina, 98100 Messina, Italy.
Nephrology and Dialysis, Centre Hospitalier Le Mans, Avenue Roubillard 194, 72000 Le Mans, France.
Nutrients. 2020 Nov 16;12(11):3519. doi: 10.3390/nu12113519.
The recent Kidney Disease Outcomes Quality Initiative (K-DOQI) guidelines suggest an early start of protein restriction, raising issues on willingness to change dietary habits. The aim of this exploratory real-life study was to report on a test of dietary products (protein-free, not previously available in France) in a large, mainly elderly, chronic kidney disease (CKD) population (220 patients, median age: 77.5 years, Charlson comorbidity index (CCI): seven, malnutrition inflammation score (MIS): five, estimated glomerular filtration rate (eGFR): 26 mL/min), also as a means to tailor further implementation strategies. Forty-nine patients (22.28%) were considered to be poor candidates for the trial (metabolically unstable or with psychological, psychiatric or logistic barriers); of the remaining 171, 80.70% agreed to participate. Patients to whom the diet was not proposed had lower eGFR and higher comorbidity (eGFR 21 vs. 27 = 0.021; MIS six vs. four : <0.001). Patients who refused were 10 years older than those who accepted (83 vs. 73 years < 0.001), with a higher CCI (eight vs. seven = 0.008) and MIS (five vs. four = 0.01). In the logistic regression, only age was significantly associated with refusal to participate (Odds ratio (OR): 5.408; 95% CI: 1.894 to 15.447). No difference was found according to low/intermediate/high frequency of weekly use of protein-free food. Our study suggests that most of the patients are ready to test new diet approaches. Only old age correlated with refusal, but frequency of implementation depended on individual preferences, underlying the importance of tailored approaches to improve adherence.
最近的肾脏病预后质量倡议(K-DOQI)指南建议早期开始限制蛋白质摄入,这引发了人们对改变饮食习惯的意愿的关注。本探索性真实世界研究的目的是报告一种饮食产品(无蛋白,在法国以前不可用)在大型、主要是老年慢性肾脏病(CKD)人群(220 例患者,中位年龄:77.5 岁,Charlson 合并症指数(CCI):7,营养不良炎症评分(MIS):5,估计肾小球滤过率(eGFR):26 mL/min)中的测试结果,同时也是为了制定进一步的实施策略。49 例患者(22.28%)被认为不适合参加试验(代谢不稳定或存在心理、精神或后勤障碍);在剩余的 171 例患者中,有 80.70%同意参加。未提出饮食方案的患者的 eGFR 较低,合并症较多(eGFR 21 比 27 = 0.021;MIS 6 比 4 :<0.001)。拒绝的患者比接受的患者年长 10 岁(83 比 73 岁 < 0.001),CCI(8 比 7 :0.008)和 MIS(5 比 4 :0.01)更高。在逻辑回归中,只有年龄与拒绝参与显著相关(优势比(OR):5.408;95%置信区间:1.894 至 15.447)。根据每周使用无蛋白食物的低/中/高频次,未发现差异。我们的研究表明,大多数患者都愿意尝试新的饮食方法。只有年龄与拒绝有关,但实施的频率取决于个人偏好,这突出了制定个性化方法来提高依从性的重要性。